DVAC Exposes Tamil Nadu Joint Director of Drugs Control, Food and Drug Administration : Caught taking Bribe for License.

Date:

Share post:

DVAC Exposes Tamil Nadu Joint Director of Drugs Control, Food and Drug Administration : Caught taking Bribe for License

PharmaGenDRx News Bureau, – July 23, 2025

03:00 PM IST

In an undergoing anti-corruption operation, the Directorate of Vigilance and Anti-Corruption (DVAC) has arrested P.U Karthikeyan, Director-in-charge of Tamil Nadu Drug Control Administration (TN DCA), charged with asking for and accepting bribes.

Karthikeyan was posted only a month ago and was caught red-handed at his own office while allegedly accepting an advance bribe of Rs.25,000. The amount was part of a larger 2 lakh demand for issuing manufacturing licenses for soap and shampoo products to a Vellore-based entrepreneur.

The complainant, S. Saravanan, proprietor of Our Green India Soap Company had submitted all required documents and paid official fees via the designated portal. When allegedly pressured to “complete formalities”, he promptly reported the matter to DVAC.

Saravanan’s swift action led to the bricks of a successful sting operation. Karthikeyan was arrested by DVAC and the bribed amount was also seized. This action by DVAC shows transparency among state regulatory bodies.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Dabur India Plant Under US FDA Scanner Over Contamination Concerns

The United States Food and Drug Administration (US FDA) has flagged serious concerns at Dabur India's manufacturing facility...

FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI

Wockhardt Limited  announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic...

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling prices for 30 essential fixed-dose combination medicines under the...

FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs

The U.S. Food and Drug Administration (FDA) issued a new draft guidance aimed at reducing unnecessary animal testing...